Business Wire

Koya Medical Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms

OAKLAND, Calif.--(BUSINESS WIRE)--Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active ...
Fox 5 San Diego

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease at the AVLS 2022 Annual Congress

OAKLAND, Calif., Oct. 24, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...
Business Wire

Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies for Lymphedema and Venous Disorders

OAKLAND, Calif.--(BUSINESS WIRE)--Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today ...
ksn.com

Koya Medical Announces Topline Results from Its Latest Trial on the Treatment of Lower Extremity Lymphedema at VENOUS2024

OAKLAND, Calif. and TAMPA, Fla., March 6, 2024 /PRNewswire/ -- Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized ...
Business Insider

Koya Medical Selected for Poster Presentation of the NILE Clinical Trial, awarded Gold medal at AMCP 2023

OAKLAND, Calif., March 13, 2023 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform venous and lymphatic care through innovative, people-centric solutions, today announced ...
vator

Koya Medical raises $26M for its wearable lymphedema therapeutic

You may not have heard of lymphedema, but there’s a decent chance you know someone who has it: an estimated 20 million Americans live with the disease, which is chronic, progressive, and incurable ...